Noninvasive follicular thyroid neoplasm with papillary-like nuclear features
A type of thyroid neoplasm
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is a type of thyroid neoplasm that exhibits certain histological characteristics similar to papillary thyroid carcinoma (PTC) but is considered to have a very low risk of malignancy. This entity was introduced to reduce overtreatment of indolent thyroid tumors.
Histopathology[edit]
NIFTP is characterized by a follicular growth pattern and nuclear features similar to those seen in papillary thyroid carcinoma. The tumor is encapsulated or well-circumscribed, and there is no evidence of invasion into the surrounding thyroid tissue or blood vessels.

The nuclear features include:
- Nuclear enlargement
- Overlapping and crowding
- Irregular nuclear contours
- Optical clearing of the nuclei

Diagnosis[edit]
The diagnosis of NIFTP is primarily based on histological examination of the thyroid tissue. It requires careful evaluation to distinguish it from other forms of thyroid carcinoma, particularly the encapsulated follicular variant of papillary thyroid carcinoma.

The criteria for diagnosing NIFTP include:
- Encapsulation or clear demarcation from surrounding tissue
- Follicular growth pattern
- Absence of true papillae
- No psammoma bodies
- No vascular or capsular invasion
Management[edit]
The management of NIFTP is less aggressive than that of other thyroid carcinomas due to its low risk of recurrence and excellent prognosis. Surgical removal of the affected lobe of the thyroid (lobectomy) is often sufficient, and total thyroidectomy is generally not required.
Prognosis[edit]
NIFTP has an excellent prognosis with a very low risk of recurrence or metastasis. The reclassification of this entity from a carcinoma to a neoplasm reflects its indolent nature and aims to prevent overtreatment.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Affordable GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit.
- Tirzepatide starting from $45.00/week and up (dose dependent)
✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian